News

TRADING UPDATES: GlobalData suspends buyback; Hemogenyx trial progress
Hemogenyx Pharma PLC - biopharmaceutical company focused on treatments for blood diseases - announces that the second patient has been successfully treated as part of the ongoing Phase I clinical ...
EARNINGS: Digital 9 net asset value falls; Skillcast swings to profit
Our task now is to carry this momentum forward into the coming year and beyond, converting our exploration success into tangible value for our shareholders." Digital 9 Infrastructure PLC - ...
Bank of Ireland says in strong position despite lower interest rate
The Dublin-based lender said net interest income fell 8% on-year in the first quarter of 2025, as expected. IT reflected lower average interest rates, with the European Central Bank's rate having ...
London close: Stocks finish solid week on a positive note
(Sharecast News) - London stocks ended the week on a positive note on Friday, buoyed by upbeat global developments and solid US employment data. The FTSE 100 index advanced 1.17% to close at 8,596.35 ...
Harbour Energy takes FID on LNG project with USD100 million capex
Harbour Energy PLC on Friday said it has taken a final investment decision alongside its partners for the Southern Energy floating liquefied natural gas export project off the coast of Argentina. The ...
AIM WINNERS & LOSERS: Gfinity starts new JV to take advantage of AI
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.
LONDON BROKER RATINGS: Citi raises Burberry, Investec cuts Hunting
Citi raises Burberry to 'buy' (neutral) - price target 925 (980) pence RBC cuts Watches of Switzerland to 'sector perform' (outperform) - price target 375 (640) pence Deutsche Bank Research raises Man ...
REITS: Why the Tide Might be Turning
We rely on ads to keep creating quality content for you to enjoy for free. Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
LONDON MARKET OPEN: Stocks rise with NatWest "in good shape"
The FTSE 100 index was up 59.69 points, 0.7%, at 8,556.49. The FTSE 250 was up 33.42 points, 0.2%, at 20,168.39, and the AIM All-Share was up 1.49 points, 0.2%, at 701.47. The Cboe UK 100 was up 0.7% ...
AstraZeneca asthma drug meets targets in phase 3 trials
The Cambridge, England-based pharmaceutical company said its Kalos and Logos phase 3 trials showed Breztri achieved statistically significant and clinically meaningful improvements in lung function ...
HSBC says global trade shift poses "serious risks" to economic growth
(Alliance News) - HSBC Holdings PLC has warned over the shift in global trade relations as posing "serious potential risks" to growth, as the bank navigates a series of "unknowns" over the economic ...
Nuformix interim loss widens as focused on advancing assets
(Alliance News) - Nuformix PLC on Friday said it has continued to "advance and exploit" assets in its portfolio, two days after noting a positive opinion from an EU committee for NXP002.